Category:chelating agents
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
Assay: | 95.00 to 100.00
|
Food Chemicals Codex Listed: | No |
Flash Point: | 32.00 °F. TCC ( 0.00 °C. ) (est)
|
Soluble in: |
| water, 1e+006 mg/L @ 25 °C (est) |
Organoleptic Properties:
Odor and/or flavor descriptions from others (if found). |
Cosmetic Information:
Suppliers:
Safety Information:
|
Hazards identification |
|
Classification of the substance or mixture |
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
None found. |
GHS Label elements, including precautionary statements |
|
Pictogram | |
|
Hazard statement(s) |
None found. |
Precautionary statement(s) |
None found. |
Oral/Parenteral Toxicity: |
Not determined
|
Dermal Toxicity: |
Not determined
|
Inhalation Toxicity: |
Not determined
|
Safety in Use Information:
Category: | chelating agents |
Recommendation for dipotassium EDTA usage levels up to: | | not for fragrance use.
|
|
Recommendation for dipotassium EDTA flavor usage levels up to: |
| not for flavor use.
|
Safety References:
References:
| dipotassium;2-[2-[carboxylatomethyl(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetate |
NIST Chemistry WebBook: | Search Inchi |
Canada Domestic Sub. List: | 2001-94-7 |
Pubchem (cid): | 16156 |
Pubchem (sid): | 134983471 |
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| acetic acid, (ethylenedinitrilo)tetra-, dipotassium salt | | dipotassium dihydrogen ethylene diamine tetraacetate | | dipotassium dihydrogen ethylenediaminetetraacetate | | dipotassium ethylenediaminetetraacetate | | dipotassium;2-[2-[carboxylatomethyl(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetate | ( | ethylenedinitrilo)tetraacetate dipotassium salt | | glycine, N,N'-1,2-ethanediylbis(N-(carboxymethyl)-, dipotassium salt | | glycine, N,N'-1,2-ethanediylbis(N-(carboxymethyl)-, potassium salt (1:2) |
Articles:
PubMed:Brand of dipotassium EDTA vacuum tube as a new source of pre-analytical variability in routine haematology testing. |
PubMed:Comparison of performance of serum and plasma in panbio dengue and Japanese encephalitis virus enzyme-linked immunosorbent assays. |
PubMed:Clinical utility of automated platelet clump count in the screening for ethylene diamine tetraacetic acid-dependent pseudothrombocytopenia. |
PubMed:Analysis of the optimal blood sampling conditions for estimation of hematopoietic progenitor cell count by the SE-9000 automated hematolyzer. |
PubMed:Final report on the safety assessment of EDTA, calcium disodium EDTA, diammonium EDTA, dipotassium EDTA, disodium EDTA, TEA-EDTA, tetrasodium EDTA, tripotassium EDTA, trisodium EDTA, HEDTA, and trisodium HEDTA. |
PubMed:Stability of ascorbic acid in serum and plasma prior to analysis. |
PubMed:Effect of pH and buffering condition on dMPV of three types of platelet concentrates. |
PubMed:Determination of dopexamine hydrochloride in human blood by high-performance liquid chromatography with electrochemical detection. |
PubMed:A manual spectrophotometric method for the measurement of serum sodium and potassium by enzyme activation. |
PubMed:Recommendations of the International Council for Standardization in Haematology for Ethylenediaminetetraacetic Acid Anticoagulation of Blood for Blood Cell Counting and Sizing. International Council for Standardization in Haematology: Expert Panel on Cytometry. |
PubMed:An evaluation of leucocyte analysis on the Coulter STKS. |
PubMed:The effect of hypotonicity on the mean platelet volume of patients with thrombo-embolism. |
PubMed:Reticulocyte count using thiazole orange. A flow cytometry method. |
PubMed:The effect of EDTA on the histochemical myofibrillar ATPase reaction. |
|